HPV testing is performed under three general categories for the management of asymptomatic women with abnormal cervical smears:
1) Reflex testing - triage of women 30 years and over with ASC-US or LSIL cytology (without an abnormal smear in the last 5 years). Lab will initiate.
2) Test of Cure - women who have been previously treated for CIN2/3 in the past should have Cytology and HPV testing performed 12 months after treatment and annually thereafter until a women tests negative for both tests on two consecutive occasions. A woman can then return to normal 3 yearly screening thereafter. Smeartaker to request, lab can initiate the second test of cure if not requested by the sample taker.
3) Specialist request.
Anatomical Pathology - Cytology
Digene HPV Typing
HPV - Cytology
Human Papilloma virus - Cytology
Collect as per normal smeartaking practice for a cervical smear and place the head of the sampling device into the SurePath collection vial.
HPV results will be reported with the corresponding Cytology request and the recommendation issued will have taken into account both the Cytology and HPV results.
“HPV Detected” results will have partial genotyping for the high-risk HPV Types 16 and 18, with the remaining high-risk types grouped as “Other”. An HPV detected result indicates the presence of a high-risk HPV type infection.
“HPV Not Detected” result indicates no presence of a high-risk HPV type infection.
“Insufficient” comment in the report indicates the specimen was unable to be tested due to insufficient cellularity or specimen.
Abbott Real-Time PCR (Abbott RT-PCR)
DNA extraction, amplification and detection for high-risk HPV types with partial genotyping for high-risk HPV types 16 and 18.
$47.81 (Exclusive of GST)
Cervical Cytology and HPV testing can be performed on the same SurePath vial. HPV is not able to be added to a leaking SurePath vial.